news_6

BeiGene Announces European Medicines Agency Acceptance of Applications for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia and Marginal Zone Lymphoma

The CLL filing is supported by two global Phase 3 trials of BRUKINSA in chronic lymphocytic leukemia covering both treatment-naïve...

news_6

Global Precision Guided Munition Market (2022 to 2030) – Featuring Lockheed Martin, BAE Systems and Raytheon Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Precision Guided Munition Market Size, Share & Trends Analysis Report by Product (Tactical Missiles, Loitering Munition), by Technology...